PURPOSE: To evaluate the feasibility of isolating and expanding endothelial progenitor cells (EPCs), in the form of late outgrowth endothelial progenitor cells (OECs), from the peripheral blood of an aged population, particularly patients affected by different forms of AMD. METHODS: Peripheral blood mononuclear cells were collected from young control subjects (n = 18) and from elderly subjects with non-AMD/low-risk dry AMD (n = 15), high-risk dry AMD (n = 6), or neovascular AMD (nvAMD; n = 32); cultured in established conditions; and observed for appearance of OEC clusters and growth characteristics on expansion. Expression of VEGF receptor-2 (KDR) in OECs after expansion was determined by Western blot. Plasma samples of study subjects were analyzed for CRP and VEGF levels. RESULTS: OEC cultures were successfully generated from a similar number of subjects in each group. After adjustment for all other variables, subjects with high-risk dry AMD had a 5.6-fold higher number of OEC clusters per 20 mL blood, and subjects with nvAMD had a 5.1-fold high number than did subjects with non-AMD/low-risk dry AMD (P < 0.05). High-risk dry AMD generated 63 times more (NS) and nvAMD 32-times more (P < 0.05) OECs on expansion of clusters than did non-AMD/low-risk dry AMD. Population doubling occurred significantly faster in cultures from nvAMD eyes compared to non-AMD/low-risk dry AMD eyes. In addition, a significant correlation between the number of OEC clusters, expanded OECs and levels of KDR was demonstrated. CONCLUSIONS: An OEC population was isolated and expanded from the blood of elderly control and AMD-affected patients and demonstrated significantly higher number of initial OEC clusters and expansion potential of OECs in patients at risk for or already affected by nvAMD. OECs may be used for further phenotypic, genetic, and functional analyses in patients with nvAMD.
PURPOSE: To evaluate the feasibility of isolating and expanding endothelial progenitor cells (EPCs), in the form of late outgrowth endothelial progenitor cells (OECs), from the peripheral blood of an aged population, particularly patients affected by different forms of AMD. METHODS: Peripheral blood mononuclear cells were collected from young control subjects (n = 18) and from elderly subjects with non-AMD/low-risk dry AMD (n = 15), high-risk dry AMD (n = 6), or neovascular AMD (nvAMD; n = 32); cultured in established conditions; and observed for appearance of OEC clusters and growth characteristics on expansion. Expression of VEGF receptor-2 (KDR) in OECs after expansion was determined by Western blot. Plasma samples of study subjects were analyzed for CRP and VEGF levels. RESULTS: OEC cultures were successfully generated from a similar number of subjects in each group. After adjustment for all other variables, subjects with high-risk dry AMD had a 5.6-fold higher number of OEC clusters per 20 mL blood, and subjects with nvAMD had a 5.1-fold high number than did subjects with non-AMD/low-risk dry AMD (P < 0.05). High-risk dry AMD generated 63 times more (NS) and nvAMD 32-times more (P < 0.05) OECs on expansion of clusters than did non-AMD/low-risk dry AMD. Population doubling occurred significantly faster in cultures from nvAMD eyes compared to non-AMD/low-risk dry AMD eyes. In addition, a significant correlation between the number of OEC clusters, expanded OECs and levels of KDR was demonstrated. CONCLUSIONS: An OEC population was isolated and expanded from the blood of elderly control and AMD-affected patients and demonstrated significantly higher number of initial OEC clusters and expansion potential of OECs in patients at risk for or already affected by nvAMD. OECs may be used for further phenotypic, genetic, and functional analyses in patients with nvAMD.
Authors: Jane Yellowlees Douglas; Ashay D Bhatwadekar; Sergio Li Calzi; Lynn C Shaw; Debra Carnegie; Sergio Caballero; Quihong Li; Alan W Stitt; Mohan K Raizada; Maria B Grant Journal: Prog Retin Eye Res Date: 2012-05-15 Impact factor: 21.198
Authors: Sergio Li Calzi; Matthew B Neu; Lynn C Shaw; Jennifer L Kielczewski; Nicanor I Moldovan; Maria B Grant Journal: Microvasc Res Date: 2010-02-25 Impact factor: 3.514
Authors: Jingsheng Tuo; Robert J Ross; Alexandra A Herzlich; Defen Shen; Xiaoyan Ding; Min Zhou; Steven L Coon; Nahed Hussein; Norman Salem; Chi-Chao Chan Journal: Am J Pathol Date: 2009-07-16 Impact factor: 4.307
Authors: Dieter Dauwe; Beatriz Pelacho; Arief Wibowo; Ann-Sophie Walravens; Kristoff Verdonck; Hilde Gillijns; Ellen Caluwe; Peter Pokreisz; Nick van Gastel; Geert Carmeliet; Maarten Depypere; Frederik Maes; Nina Vanden Driessche; Walter Droogne; Johan Van Cleemput; Johan Vanhaecke; Felipe Prosper; Catherine Verfaillie; Aernout Luttun; Stefan Janssens Journal: J Am Heart Assoc Date: 2016-04-18 Impact factor: 5.501
Authors: Sa Do Kang; Tim A Carlon; Alexandra E Jantzen; Fu-Hsiung Lin; Melissa M Ley; Jason D Allen; Thomas V Stabler; N Rebecca Haley; George A Truskey; Hardean E Achneck Journal: Ann Biomed Eng Date: 2013-04-19 Impact factor: 3.934
Authors: John D Stroncek; Bryan S Grant; Melissa A Brown; Thomas J Povsic; George A Truskey; William M Reichert Journal: Tissue Eng Part A Date: 2009-11 Impact factor: 3.845
Authors: Ruei-Zeng Lin; Rafael Moreno-Luna; Rocio Muñoz-Hernandez; Dan Li; Shou-Ching S Jaminet; Arin K Greene; Juan M Melero-Martin Journal: Angiogenesis Date: 2013-05-01 Impact factor: 9.596